Results 111 to 120 of about 3,568 (149)

[Exploring the health education model for chronic hepatitis C micro-elimination in Guizhou Province from a global perspectives]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2020
Luo XH, Liang YD, Peng H, Ning JH.
europepmc   +1 more source

[Analysis of HCV genotype distribution characteristics in the Hotan region]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wubuliaishan M, Lyu HL, Aibi A, Bai JZ, Zhang DY, Maitikuwan N, Chen L, Zhang WY, Lu JF.   +8 more
europepmc   +1 more source

[Exploring the harm elimination model with regard to viral hepatitis C in China's western region]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wu X, Yang Y, Cao Q, Gan LS, Wu GH, Cai DC.   +5 more
europepmc   +1 more source

[Current status of genotyping of pregnant women with hepatitis C and its impact on pregnancy outcomes]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Cai M, Ding Y, Li QX, Jiang YL, Zhang YW, Yue X.   +5 more
europepmc   +1 more source

[Study on hepatitis C intervention measures to improve the referral, treatment, and cure rate in hospitals]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Cheng HH, Cai DC.
europepmc   +1 more source

[A phase Ⅲ clinical study to evaluate the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of adults with chronic hepatitis C]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wei L, Shang J, An X, Zhang GQ, Guan YJ, Piao HX, Jin JL, Bai L, Yang XX, Yang DK, Luo XH, Yuan SF, Zhao YR, Ma YJ, Li GM, Lin F, Wu XP, Geng JW, Zou GZ, Chang JB, Gong ZJ, Mao XR, Zhu J, Guo WT, He QW, Luo L, Zhuang YL, Xie HM, Zhang YJ.   +28 more
europepmc   +1 more source

肝病患者血清碱性谷胱苷肽S转移酶放射免疫测定及临床意义

Zhongshan Daxue xuebao. Yixue kexue ban, 1991
应用放射免疫测定法(RIA)检测277例肝病患者血清碱性谷胱苷肽S转移酶(B-GST),并以54例健康人及28例非肝病作对照,研究结果发现各型肝病血清B-GST均明显升高,提示B-GST是一项反映肝损害的敏感指标;它对急性肝炎的诊断意义与丙氨酸转氨酶(ALT)相若,但对反映慢性肝炎及轻微肝损害则较ALT敏感,且具有更好的肝胆特异性,还对肝炎预后及反映肝脏病理改变有较好的参考意义.
doaj  

[Analysis of the efficacy and safety profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of patients with chronic hepatitis C with failed DAAs therapy]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Guo Y, Zhao ST, Zhu Y, Yang C, Li JP, Zhang LH, Yang CM, Xiong HG, Zhang D, Tian GJ, Gao BH, Guo L, Xia J.   +12 more
europepmc   +1 more source

[Elimination of hepatitis C, our progress, challenges and hopes]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2020
Rao HY, Li MY, Wei L.
europepmc   +1 more source

[Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2021
He N, Hao S, Feng G, Gao J, Kong FJ, Ren ZX, Xu MQ, Yang YQ.   +7 more
europepmc   +1 more source